Karolinska Development aims to create value for investors, patients, and researchers by developing innovations from world class science into products that can be sold or out-licensed with high returns. An exclusive deal flow agreement with Karolinska Institutet Innovations AB, along with other cooperation agreements with leading Nordic universities, delivers a continuous flow of innovations. Today, the portfolio consists of 36 projects, of which 15 are in clinical development.

VIEW PORTFOLIO BY THERAPEUTIC AREA:
Click to view portfolio progress

© 2012 Karolinska Development AB (publ)
Registered office: Solna | org. nr. 556707-5048 | Contact: info@karolinskadevelopment.com